ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
Gordts PL, Nock R, Son NH, Ramms B, Lew I, Gonzales JC, Thacker BE, Basu D, Lee RG, Mullick AE, Graham MJ, Goldberg IJ, Crooke RM, Witztum JL, Esko JD.
Gordts PL, et al.
J Clin Invest. 2016 Aug 1;126(8):2855-66. doi: 10.1172/JCI86610. Epub 2016 Jul 11.
J Clin Invest. 2016.
PMID: 27400128
Free PMC article.